PASW
Ping An Biomedical Co., Ltd.Company with tickers: PASW
CIK
1897532
CUSIP
G5880S105
Shares Outstanding
124,550,000
Website
https://newbrandcashmere.com
Investor Relations
https://newbrandcashmere.com/investors/
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | 34,147,936 | CNY | 2025-09-30 | 20-F | 2026-01-30 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | 33,198,431 | CNY | 2025-09-30 | 20-F | 2026-01-30 |
| Gross Profit | 949,505 | CNY | 2025-09-30 | 20-F | 2026-01-30 |
| Operating Expenses | 15,650,976 | CNY | 2025-09-30 | 20-F | 2026-01-30 |
| Research & Development | — | ||||
| Operating Income | -14,701,471 | CNY | 2025-09-30 | 20-F | 2026-01-30 |
| Net Income | -12,829,206 | CNY | 2025-09-30 | 20-F | 2026-01-30 |
| EPS (Basic) | -0.69 | CNY/shares | 2025-09-30 | 20-F | 2026-01-30 |
| EPS (Diluted) | -0.69 | CNY/shares | 2025-09-30 | 20-F | 2026-01-30 |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Segment (CNY)
| Component | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Sales Of Yarns | 77,040,009 | 83,269,024 | 32,421,473 |
| Sales Of Finished Garments | 5,523,742 | 4,353,371 | 1,726,463 |